Drug Pipeline

YKST02 Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
3
Active Studies
2
Recruiting
2
Top Sponsors
Active Studies by Phase
Phase 1
2
Early Phase 1
1
Active Trials
NCT IDTitleConditionStatus
Phase 1
NCT06574568 A Study of YKST02 in Participants With Relapsed or Refractory Multiple Myeloma Relapsed or Refractory Multiple Myeloma Recruiting
NCT07512947 Study of YKST02 Alone or in Combination With YK012 in Patients With Active or Refractory… System Lupus Erythematosus(SLE) Not Yet Recruiting
Early Phase 1
NCT07498673 A Study of YKST02 in Participants With Primary IgA Nephropathy Primary IgA Nephropathy Recruiting
Sponsors Running YKST02 Trials
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology (2) Excyte Biopharma Ltd (1)
Disease Areas
Multiple Myeloma (1) Lupus (SLE) (1)
Get alerts when YKST02 trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free